StockNews.com Initiates Coverage on Retractable Technologies (NYSE:RVP)

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVPGet Free Report) in a research report issued on Friday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Performance

Shares of Retractable Technologies stock opened at $0.76 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51. Retractable Technologies has a 1 year low of $0.71 and a 1 year high of $1.34. The firm’s 50-day simple moving average is $0.87 and its 200-day simple moving average is $1.01. The firm has a market cap of $22.75 million, a PE ratio of -1.25 and a beta of 2.06.

Retractable Technologies (NYSE:RVPGet Free Report) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The business had revenue of $6.03 million during the quarter.

Insider Buying and Selling

In related news, CEO Thomas J. Shaw acquired 71,422 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The shares were acquired at an average cost of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the purchase, the chief executive officer now directly owns 14,743,907 shares in the company, valued at $12,090,003.74. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders have bought a total of 182,416 shares of company stock valued at $164,400 in the last quarter. Company insiders own 54.60% of the company’s stock.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Read More

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.